90321899 - RYLEBI

Information

  • Trademark
  • 90321899
  • Serial Number
    90321899
  • Filing Date
    November 16, 2020
    4 years ago
  • Transaction Date
    August 01, 2024
    4 months ago
  • Status Date
    August 01, 2024
    4 months ago
  • Published for Opposition Date
    December 21, 2021
    3 years ago
  • Location Date
    February 15, 2022
    2 years ago
  • Status Code
    734
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BAYLISS,HUNTER A
  • Attorney Name
    Michael T. Olsen
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
4
Mark Identification
RYLEBI
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations and substances for the treatment of neurological conditions, disorders, and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, chron's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders, and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; Medicinal infusions for treating neurological conditions, disorders, and diseases; Pure extracts of medicinal plants and herbs for medical purposes; Dietetic foods adapted for medical purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes
  • TR0010: The wording RYLEBI has no meaning in a foreign language.
Case File Event Statements
  • 11/19/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/15/2021 - 3 years ago
    8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/15/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/26/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/3/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/3/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/15/2021 - 3 years ago
    9 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 9/15/2021 - 3 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/15/2021 - 3 years ago
    7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/1/2021 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/1/2021 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/2/2021 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/14/2021 - 3 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/14/2021 - 3 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/14/2021 - 3 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/14/2021 - 3 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/15/2021 - 3 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/21/2021 - 3 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/15/2022 - 2 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/1/2021 - 3 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/21/2021 - 3 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/8/2022 - 2 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/8/2022 - 2 years ago
    24 - SOU EXTENSION 1 FILED Type: EXT1
  • 8/8/2022 - 2 years ago
    25 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/10/2022 - 2 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/15/2023 - a year ago
    28 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/15/2023 - a year ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/15/2023 - a year ago
    29 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 2/17/2023 - a year ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/18/2024 - 11 months ago
    35 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/18/2024 - 11 months ago
    36 - SOU EXTENSION 4 FILED Type: EXT4
  • 1/18/2024 - 11 months ago
    37 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 7/13/2023 - a year ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/13/2023 - a year ago
    32 - SOU EXTENSION 3 FILED Type: EXT3
  • 7/13/2023 - a year ago
    33 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 7/15/2023 - a year ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/20/2024 - 11 months ago
    38 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/1/2024 - 4 months ago
    39 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/1/2024 - 4 months ago
    42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/1/2024 - 4 months ago
    41 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 8/1/2024 - 4 months ago
    40 - SOU EXTENSION 5 FILED Type: EXT5